[1]
N. Nafrialdi, N. M. Handini, I. Instiaty, and I. P. Wijaya, “A cost-effectiveness and safety analysis of dual antiplatelet therapy comparing aspirin–clopidogrel to aspirin–ticagrelor in patients with acute coronary syndrome”, Med J Indones, vol. 27, no. 4, pp. 262-70, Dec. 2018.